title: Repetitive prenatal glucocorticoid therapy reduces oxidative stress in the lungs of preterm lambs.
abstract: Repetitive courses of maternal prenatal glucocorticoids are often used in high-risk pregnancies with threatening preterm labor to induce lung maturation, but the effects on the cellular oxidant-antioxidant balance in the fetal lung have not been evaluated. We investigated the effect of repetitive treatment with glucocorticoids, beginning early in gestation, on oxidative stress in the preterm ovine lung. Pregnant ewes were randomized to receive one, two, three, or four doses of 0.5 mg/kg betamethasone or saline placebo at 7-day intervals on 104, 111, 118, and 124 days gestation (n = 11 for each group). All lambs were delivered preterm at 125 days gestation, and lung tissue was assayed for antioxidant enzymes, lipid hydroperoxides, and carbonyl proteins. Lung manganese superoxide dismutase, catalase, and glutathione peroxidase activity increased after 1 dose of betamethasone given at 104 days gestation, whereas copper-zinc superoxide dismutase activity increased after 2 doses given at 104 and 111 days gestation. The activity of all four antioxidant enzymes further increased with additional doses and was maximal after four doses of betamethasone. Lung lipid hydroperoxide levels and carbonyl protein content decreased stepwise after each dose of betamethasone and were lowest after four doses. Repetitive prenatal glucocorticoid therapy increases antioxidant enzyme activity and reduces oxidative stress in the lungs of preterm lambs, and these effects begin early in gestation and persist for 2-3 wk.
authors.affiliation: Department of Pediatrics, Charles R. Drew University of Medicine and Science 90059, USA. fwalther@ucla.edu
authors.forename: F J
authors.initials: FJ
authors.lastname: Walther
authors.forename: A H
authors.initials: AH
authors.lastname: Jobe
authors.forename: M
authors.initials: M
authors.lastname: Ikegami
mesh_terms: D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000975:Antioxidants / Q000378:metabolism; D001623:Betamethasone / Q000494:pharmacology; D002374:Catalase / Q000378:metabolism; D004247:DNA / Q000378:metabolism; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D005979:Glutathione Peroxidase / Q000378:metabolism; D066298:In Vitro Techniques; D008054:Lipid Peroxides / Q000378:metabolism; D008168:Lung / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D018384:Oxidative Stress / Q000187:drug effects*; D011247:Pregnancy; D011506:Proteins / Q000378:metabolism; D012756:Sheep; D013482:Superoxide Dismutase / Q000378:metabolism
chemical_list: D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D005938:Glucocorticoids; D008054:Lipid Peroxides; D011506:Proteins; D004247:DNA; D001623:Betamethasone; D002374:Catalase; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase